OPNT

Opiant Pharmaceuticals, Inc. Common Stock
OPNT

Delisted

OPNT was delisted on the 1st of March, 2023.

Back to rankings

35 hedge funds and large institutions have $32.7M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.14M
2
+$1.78M
3
+$1.31M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$961K
5
PHP
Parkman Healthcare Partners
Connecticut
+$772K

Top Sellers

1
-$90.5K
2
-$27.8K
3
-$19K
4
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$10.3K
5
NFSG
Newbridge Financial Services Group
Florida
-$8.95K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.37M
2
$5.29M
3
$3.55M
4
$2.63M
5
$2.14M
6
$1.78M
7
$1.66M
8
$1.31M
9
$1.29M
10
$1.14M
11
$976K
12
$824K
13
$772K
14
$638K
15
$635K
16
$418K
17
$406K
18
$268K
19
$204K
20
$163K
21
$55K
22
$37K
23
$31K
24
$30K
25
$13K
1
2